(Oslo, 5th of April 2022) Medistim ASA (OSE: MEDI) is a niche market leader
within ultrasound technology with headquarters in Oslo, Norway. Medistim
develops and commercializes medical equipment for use within cardiac, vascular
and transplant surgery. 

Medistim is proud to announce that our CEO, Kari E. Krogstad, has been named as
the winner of the Arthur D. Little's Nordic Life Science Award for 2021. The
prize was awarded at a ceremony in Stockholm on April 4, 2022.
The Arthur D. Little Nordic Life Science Award is given to a person in the
Nordic region that has demonstrated outstanding management and leadership in the
Life Science industry. The business shall be built on a strong entrepreneurship
and a high scientific level. The prize is awarded annually since 2002.

"With a persistent, international, and long-term perspective, Kari has
successfully built Medistim to become a global niche market leader within
ultrasound technology, systematically moving the company from technology
oriented to customer/market focused. Also, being highly active on the Norwegian
life science scene over many years and having dedicated her whole career to the
industry, Kari is a true source of inspiration to many life science
professionals in the Nordics," says Ulrica Sehlstedt, Managing Partner and
Global Head of Healthcare and Life Sciences in Arthur D. Little.

"I am honored by this recognition, and it adds to my motivation for doing what I
love the most